Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 2/20 | 0.32 |
| ▸ | SCN8A | Q9UQD0 | 2/20 | 0.32 |
| ▸ | SCN10A | Q9Y5Y9 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.30 |
| ▸ | TUBB | P07437 | 1/20 | 0.30 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.30 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.30 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.30 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.30 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.30 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22402103 | 0.96 | HTT (0.38) | HTTSMN1; SMN2RXFP1ALDH1A1DHODH | |
| SCHEMBL31348977 | 0.92 | HTT (0.37) | HTTSMN1; SMN2RXFP1ALDH1A1SCN8A | |
| SCHEMBL20846715 | 0.91 | HTT (0.34) | HTTSMN1; SMN2RXFP1ALDH1A1DHODH | |
| SCHEMBL1766937 | 0.90 | RXFP1 (0.35) | RXFP1MEN1KMT2APOLBGPBAR1 | |
| SCHEMBL22402119 | 0.88 | DHODH (0.34) | HTTSMN1; SMN2RXFP1DHODHSCN8A | |
| SCHEMBL31348989 | 0.87 | HTT (0.38) | HTTSMN1; SMN2RXFP1ALDH1A1SCN8A | |
| SCHEMBL22402095 | 0.87 | HTT (0.36) | HTTSMN1; SMN2RXFP1ALDH1A1DHODH | |
| SCHEMBL20846830 | 0.86 | KCNK3 (0.36) | RXFP1DHODHMEN1KMT2APOLB | |
| SCHEMBL1766327 | 0.86 | RXFP1 (0.35) | RXFP1MEN1KMT2AGPBAR1KDM4E | |
| SCHEMBL1766965 | 0.86 | KDM4E (0.36) | RXFP1MEN1KMT2APOLBGPBAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230226037-A1 | PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2023-07-20 | — | — | US | disclosed |
| US-11696913-B2 | Prolonged ectoparasite-controlling agent for animal | MITSUI CHEMICALS AGRO, INC. (JP) | 2023-07-11 | — | — | US | disclosed |
| US-20200281914-A1 | PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL | MITSUI CHEMICALS AGRO, INC. (JP) | 2020-09-10 | — | — | US | disclosed |
| WO-2019059412-A1 | PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL | MITSUI CHEMICALS AGRO, INC. (JP) | 2019-03-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11696913-B2 | Prolonged ectoparasite-controlling agent for animal | MTX1, ENPP1, CAT | HTT 1020/4885SMN1; SMN2 1114/4885RXFP1 1867/4885 |
| US-20230226037-A1 | PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL | MTX1, ENPP1, CAT | HTT 1020/4885SMN1; SMN2 1114/4885RXFP1 1867/4885 |
| US-20200281914-A1 | PROLONGED ECTOPARASITE-CONTROLLING AGENT FOR ANIMAL | MTX1, ENPP1, CAT | HTT 1020/4885SMN1; SMN2 1114/4885RXFP1 1867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.